Evidence map›Paper›PMID 31472902›Full record

ArticleKidney international2019

Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndrome.

Ashish K Solanki, Eugen Widmeier, Ehtesham Arif, Shailza Sharma, Ankana Daga, Pankaj Srivastava, Sang-Ho Kwon, Hannah Hugo, Makiko Nakayama, Nina Mann and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Biallelic pathogenic variants inJournal of medical genetics · 2026
    Article
  3. Mechanisms of podocyte injury in genetic kidney disease.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. GWAS in Mice Maps Susceptibility to HIV-Associated Nephropathy to theJournal of the American Society of Nephrology : JASN · 2022
    Article
  8. Renal cell markers: lighthouses for managing renal diseases.American journal of physiology. Renal physiology · 2021
    Article
  9. Article
  10. Review
  11. Detrimental effects of hypoxia on glomerular podocytes.Journal of physiology and biochemistry · 2021
    Review
  12. Article
  13. Genetic Disorders of the Glomerular Filtration Barrier.Clinical journal of the American Society of Nephrology : CJASN · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 4 countries.

Ashish K SolankiDepartment of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, South Carolina, USA.
Eugen WidmeierDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Medicine IV, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ehtesham ArifDepartment of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, South Carolina, USA.
Shailza SharmaDepartment of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, South Carolina, USA.
Ankana DagaDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pankaj SrivastavaDepartment of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, South Carolina, USA.
Sang-Ho KwonDepartment of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, USA.
Hannah HugoDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Makiko NakayamaDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Nina MannDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Amar J MajmundarDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Wei TanDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Heon Yung GeeDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Pharmacology, Brain Korea 21 Program for Leading Universities & Students (PLUS) Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea.
Caroline E SadowskiDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Choni RinatDivision of Pediatric Nephrology, Shaare Zedek Medical Center, The Hadassah-Hebrew University School of Medicine, Jerusalem, Israel.
Rachel Becker-CohenDivision of Pediatric Nephrology, Shaare Zedek Medical Center, The Hadassah-Hebrew University School of Medicine, Jerusalem, Israel.
Carsten BergmannDepartment of Medicine IV, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Seymour RosenDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Michael SomersDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Shirlee ShrilDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Tobias B HuberDepartment of Medicine IV, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; III Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Biological Signalling Studies (BIOSS) Center for Biological Signaling Studies, Albert-Ludwigs-University, Freiburg, Germany.
Shrikant ManeDepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Friedhelm HildebrandtDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: friedhelm.hildebrandt@childrens.harvard.edu.
Deepak NihalaniDepartment of Medicine, Nephrology Division, Medical University of South Carolina, Charleston, South Carolina, USA. Electronic address: nihalani@musc.edu.
Boston Children's Hospital · USMedical University of South Carolina · USShaare Zedek Medical Center · ILAugusta University · USBeth Israel Deaconess Medical Center · USUniversität Hamburg · DEUniversity of Freiburg · DEYale University · US

Funding

Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI SOMLO, STEFAN · 2008 to 2022
$16.8M
Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
Myo1c Participates in Podocyte Junction Formation Through Interaction with Neph1R01DK087956 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NIHALANI, DEEPAK · 2010 to 2018
$3.5M
Regulation of exosome release and its role in acute kidney injury.R01DK120510 · NIDDK · AUGUSTA UNIVERSITY · PI KWON, KENNETH · 2019 to 2023
$1.7M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysiS10OD018521 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2015 to 2015
$890k
Preclinical therapeutic validation of a novel therapeutic lead for treating glomerular diseases such as focal and segmental glomerulosclerosisR56DK116887 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI NIHALANI, DEEPAK, SCHNELLMANN, RICK G · 2018 to 2018
$100k
NHGRI NIH HHS U54 HG006504NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK076683NIDDK NIH HHS R01 DK087956NIDDK NIH HHS R01 DK120510NIDDK NIH HHS R56 DK116887NIDDK NIH HHS T32 DK007726NIH HHS S10 OD018521
6 · The paper itself

Abstract

Steroid-resistant nephrotic syndrome is a frequent cause of chronic kidney disease almost inevitably progressing to end-stage renal disease. More than 58 monogenic causes of SRNS have been discovered and majority of known steroid-resistant nephrotic syndrome causing genes are predominantly expressed in glomerular podocytes, placing them at the center of disease pathogenesis. Herein, we describe two unrelated families with steroid-resistant nephrotic syndrome with homozygous mutations in the KIRREL1 gene. One mutation showed high frequency in the European population (minor allele frequency 0.0011) and this patient achieved complete remission following treatment, but later progressed to chronic kidney disease. We found that mutant KIRREL1 proteins failed to localize to the podocyte cell membrane, indicating defective trafficking and impaired podocytes function. Thus, the KIRREL1 gene product has an important role in modulating the integrity of the slit diaphragm and maintaining glomerular filtration function.

Indexed as

AdolescentAge of OnsetCell LineChildChild, PreschoolConsanguinityDisease ProgressionDNA Mutational AnalysisDrug ResistanceExome SequencingFemaleFollow-Up StudiesGene FrequencyGlomerular Basement MembraneGlucocorticoidsHomozygoteGlucocorticoidsKIRREL1 protein, humanKirrel1 protein, mouseMembrane Proteinsnephrinfocal segmental glomerulosclerosisKIRREL1minimal change diseasesteroid-resistant nephrotic syndrome

Identifiers

PMID31472902
PMCPMC6756928
OpenAlexW2960628185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.